[removed]Federal Register Vol. 69, No[removed]Monday, March 15, [removed]Notices application for ZELNORM (U.S. Patent No. 5,510,353) from Novartis - U.S. Track - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2004-03-15 06:59:10 Pharmaceutical sciences Research Clinical research Pharmacology United States Public Health Service New Drug Application FDA Fast Track Development Program Investigational New Drug Food and Drug Administration Drug safety Medicine		[removed]Federal Register / Vol. 69, No[removed]Monday, March 15, [removed]Notices application for ZELNORM (U.S. Patent No. 5,510,353) from Novartis Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 42,00 KB Share Document on Facebook

	Morphochem’s Investigational New Drug (IND) application accepted by FDA – Novel antibacterial for IV treatment of CDI ready to move to Phase 2 Munich (Germany), June 22, 2016 — Morphochem, a clinical-stage pharmace DocID: 1uvYN - View Document
	Guidance for Industry Content and Format of Investigational New Drug Applications (INDs) for Phase 1 Studies of Drugs, Including Well-Characterized, Therapeutic, DocID: 1sDEk - View Document
	Emergency Use: means the use of a test article on a human subject in a life-threatening situation in DocID: 1riMu - View Document
	Microsoft Word - 7494fnl.doc DocID: 1qYy2 - View Document
	Microsoft Worddoc DocID: 1qVAJ - View Document